Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA.
Neurosurgery. 2013 Mar;72(3):415-27. doi: 10.1227/NEU.0b013e3182804aa2.
One response to randomized trials like the International Subarachnoid Aneurysm Trial has been to adopt a "coil first" policy, whereby all aneurysms be considered for coiling, reserving surgery for unfavorable aneurysms or failed attempts. Surgical results with middle cerebral artery (MCA) aneurysms have been excellent, raising debate about the respective roles of surgical and endovascular therapy.
To review our experience with MCA aneurysms managed with microsurgery as the treatment of first choice.
Five hundred forty-three patients with 631 MCA aneurysms were managed with a "clip first" policy, with 115 patients (21.2%) referred from the Neurointerventional Radiology service and none referred from the Neurosurgical service for endovascular management.
Two hundred eighty-two patients (51.9%) had ruptured aneurysms and 261 (48.1%) had unruptured aneurysms. MCA aneurysms were treated with clipping (88.6%), thrombectomy/clip reconstruction (6.2%), and bypass/aneurysm occlusion (3.3%). Complete aneurysm obliteration was achieved with 620 MCA aneurysms (98.3%); 89.7% of patients were improved or unchanged after therapy, with a mortality rate of 5.3% and a permanent morbidity rate of 4.6%. Good outcomes were observed in 92.0% of patients with unruptured and 70.2% with ruptured aneurysms. Worse outcomes were associated with rupture (P = .04), poor grade (P = .001), giant size (P = .03), and hemicraniectomy (P < .001).
At present, surgery should remain the treatment of choice for MCA aneurysms. Surgical morbidity was low, and poor outcomes were due to an inclusive policy that aggressively managed poor-grade patients and complex aneurysms. This experience sets a benchmark that endovascular results should match before considering endovascular therapy an alternative for MCA aneurysms.
对像国际蛛网膜下腔出血试验这样的随机试验的一种反应是采用“先线圈”策略,即所有动脉瘤都考虑进行线圈治疗,将手术保留给不利的动脉瘤或失败的尝试。大脑中动脉(MCA)动脉瘤的手术结果非常出色,这引发了关于手术和血管内治疗各自作用的争论。
回顾我们采用显微手术作为首选治疗方法治疗 MCA 动脉瘤的经验。
543 例 631 个 MCA 动脉瘤患者采用“夹闭优先”策略进行治疗,其中 115 例(21.2%)患者来自神经介入放射科,没有患者因血管内治疗而从神经外科转来。
282 例(51.9%)患者为破裂动脉瘤,261 例(48.1%)为未破裂动脉瘤。MCA 动脉瘤采用夹闭(88.6%)、血栓切除术/夹闭重建(6.2%)和旁路/动脉瘤闭塞(3.3%)进行治疗。620 个 MCA 动脉瘤完全闭塞(98.3%);治疗后 89.7%的患者改善或无变化,死亡率为 5.3%,永久性发病率为 4.6%。未破裂和破裂动脉瘤的良好结局分别为 92.0%和 70.2%。较差的结局与破裂(P=0.04)、较差的分级(P=0.001)、巨大尺寸(P=0.03)和半脑切除术(P<0.001)相关。
目前,手术应仍然是 MCA 动脉瘤的治疗选择。手术发病率低,不良结局是由于采取了积极治疗低分级患者和复杂动脉瘤的包容政策。这一经验为血管内治疗作为 MCA 动脉瘤的替代方法提供了一个基准,即血管内治疗结果应该与之相匹配。